CinCor Pharma, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2022.

Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
03 Nov 2022

Quick Takeaways

  • CinCor Pharma, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2022.
  • Headline metric: Return On Equity -37%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-285%</span>.
  • Most recent SEC facts end date: 03 Nov 2022.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2022-11-03) highlights Return On Equity -37.2%, Return On Assets -16.6%, and Current Ratio 51.96x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

1.0/100

Weak Confidence low

Return On Equity

-37%

Metric score 0.0/100

Return On Assets

-17%

Metric score 0.0/100

Financial Health

Current Ratio
51.96x

Strengths

No strong signals yet.

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

-37%

YoY: -285%

Industry median: -43% (n=675)

View history

Return On Assets

-17%

YoY:

Industry median: -47% (n=673)

View history

Current Ratio

51.96x

YoY:

Industry median: 3.39x (n=667)

View history

NetIncomeLoss YoY

-132%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -37% -285%
Return On Assets -17%

Financial Health

Metric Latest value YoY change
Current Ratio 51.96x

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -132%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 43,764,323
Common Stock, Shares, Outstanding 43,764,323
Common Stock, Value, Issued $438
Weighted Average Number of Shares Outstanding, Basic 40,806,123 +2246%
Weighted Average Number of Shares Outstanding, Diluted 40,806,123 +2246%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $53,939,275 +281%
General and Administrative Expense $28,595,335 +49%
Operating Income (Loss) $82,534,610 -189%
Nonoperating Income (Expense) $8,530,751 -195%
Earnings Per Share, Basic -0.51 +90%
Earnings Per Share, Diluted -0.51 +90%
Cash and Cash Equivalents, at Carrying Value $292,556,851
Assets, Current $529,019,366
Property, Plant and Equipment, Net $99,722
Assets $529,119,088
Accounts Payable, Current $2,588,400
Employee-related Liabilities, Current $0
Accrued Liabilities, Current $2,481,232
Liabilities, Current $10,181,519
Accumulated Other Comprehensive Income (Loss), Net of Tax $883,417
Retained Earnings (Accumulated Deficit) $136,452,934
Stockholders' Equity Attributable to Parent $518,937,569
Liabilities and Equity $529,119,088
Common Stock, Shares Authorized 95,000,000
Common Stock, Par or Stated Value Per Share 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $292,556,851 +106%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $21,149,210 -134%
Additional Paid in Capital $656,273,482

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY